SCHEMBL2544657

SCHEMBL2544657

OCCCOc1n[nH]c2cncc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12

nearest known ligand 0.62

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 18/20 0.62
EGFR P00533 15/20 0.62
ERBB3 P21860 1/20 0.45
ERBB4 Q15303 1/20 0.45
AURKA O14965 1/20 0.43
RPS6KB1 P23443 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2520501 0.93 ERBB2 (0.57) ERBB2EGFRERBB3ERBB4AURKA
SCHEMBL5531018 0.92 ERBB2 (0.59) ERBB2EGFRERBB3ERBB4AURKA
SCHEMBL2520799 0.92 ERBB2 (0.57) ERBB2EGFRERBB3ERBB4AURKA
SCHEMBL2520860 0.90 ERBB2 (0.57) ERBB2EGFR
SCHEMBL2544330 0.89 ERBB2 (0.69) ERBB2EGFRERBB3ERBB4
SCHEMBL5520007 0.87 EGFR (0.65) ERBB2EGFR
SCHEMBL2514411 0.87 ERBB2 (0.54) ERBB2EGFR
SCHEMBL2542968 0.86 EGFR (0.71) ERBB2EGFR
SCHEMBL2535974 0.86 EGFR (0.71) ERBB2EGFR
SCHEMBL2542585 0.86 ERBB2 (0.55) ERBB2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838712-B8 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2011-10-12 EP disclosed
EP-1838712-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2007-10-03 EP disclosed
WO-2006064196-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2006-06-22 WO disclosed